Skip to main content

Table 1 Patient, tumor and treatment characteristics

From: Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer

Patient

Gender

Primary tumor location

TN Classification

Treatment intent

Resection of duodenum

Volume [ccm]

OARs within or immediately adjacent to targets

GTV

CTV

1

M

head

pT3 pN0

primary

yes

25.4

204.4

Small bowel, large bowel, liver, left kidney

2

M

head

pT2 pN0

primary

yes

89.9

286.3

Small bowel

3

F

head

cT3 cN0

primary

yes

58.2

144.2

Small bowel, liver

4

M

body

cT4 cN1

primary

no

123.0

356.7

Duodenum, small bowel, liver, large bowel

5

M

body + tail

pT3 pN0

adjuvant

(individualized treatment)

no

39.0

577.3

Duodenum, small bowel, liver, stomach, large bowel

6

M

body

cT4 cN1

primary

no

90.7

197.7

Duodenum, small bowel, stomach, large bowel